Elizabeth H.Z. Thompson is stepping down as Executive Vice President and Head of Research and Development at Acadia Pharmaceuticals, effective October 23, 2026. She will remain with the company in a limited consulting capacity through December 31, 2026. The firm is currently identifying her replacement for the role. Acadia Pharmaceuticals Inc. develops and commercializes treatments for central nervous system disorders.
